October 2024

• All the links have been checked and are working properly.​

  • MGR003 US clinical trials from 5 to 6 

  • ARX-788 US clinical trials from 5 to 6 

  • SGN-B6A US clinical trials from 2 to 3 

  • Telisotuzumab vedotin (ABBV-399) US clinical trials from 5 to 6 

​

August 2024

• All the links have been checked and are working properly.

  • MGR-003: US clinical trials from 4 to 5

  • Telisotuzumab vedotin (ABBV-399): US clinical trials from 6 to 5

​

June 2024

• All the links have been checked and are working properly.

  • ARX-788: US clinical trials from 6 to 5

 

April 2024

• All the links have been checked and are working properly.

  • Plinabulin: US clinical trials from 1 to 7

  • Tetrodotoxin: Chinese clinical trials from 0 to 1, US Clinical trial is Phase 2 so will be moved to that page.

  • ARX-788:  clinical trials have been consolidated from Phases 1 and 2 to Phase 3. US clinical trials from 1 to 6

  • BT8009: clinical trials have been consolidated from Phases 1 and 2 to Phase 3.

  • MRG003: clinical trials have been consolidated from Phases 1 and 2 to Phase 3.

  • SGN-B6A: clinical trials have been consolidated from Phase 1 to Phase 3.

  • Telisotuzumab vedotin (ABBV-399): clinical trials have been consolidated from Phase 2 to Phase 3.  

 

December 2023

• All the links have been checked and are working properly.

  • Upifitamab rilsodotin (XMT-1536): "[3+]" to "[1+]" under US - Active Clinical Trials.

  • ​Telisotuzumab vedotin (ABBV-399): Changed “[4+]” to “[6+]” under US – Active Clinical Trials.

  • Most recently the FDA paused Upifitamab rilsodotin trials: FDA Pauses Upifitamab Rilsodotin Trials in Platinum-Sensitive Ovarian Cancer (cancernetwork.com).

  • Plitidepsin: [Link] under Company/Institution has been updated.

​

October 2023

• All the links have been checked and are working properly.

• Plitidepsin: The compound has been removed as it currently has active Phase 3 clinical trial. Plitidepsin is moved to Phase 2 for an active clinical trial for Coronavirus.

​

August 2023

• All the links have been checked and were working properly.

​

June 2023

• The new UPDATE report was discussed and will be posted for June 2023.

• All the links have been checked and were working properly.

• Marizomib (Salinosporamide A; NPI-0052) is now in the Bristol Myers Squibb pipeline.

​

April 2023

• The new UPDATE report was discussed and will be posted for April 2023.

• The following clinical trial numbers have changed:

• Ladiratuzumab vedotin (SGN-LIV1A) a. “[5+]” to “[4+]” under US – Active Clinical Trials

​

February 2023

• All the links have been checked and were working properly. Recent changes in the number of active clinical trials in Phase 3 are shown below.

• Plitidepsin has a new US Active Phase 3 trial that is updated to the Phase 3 webpage.

• Upiftamab rilsodotin (XMT-1536) has a new US Active and European Active Phase 3 trial that is updated to the Phase 3 webpage.

​

December 2022

• All the links have been checked and were working properly. The number of clinical trials in Phase 3 is currently reflected on the website.  

​

September 2022

• During September copyright notices were posted on the top and bottom of this page.

• Plinabulin has 5 US Active Trials.

• XMT-1536 (upifitamab rilsodotin) has a new US Active Phase 3 trial has been added to the Phase 3 webpage.